WPP-201

AXP000233.1 · Phage therapy

Platform
phage cocktail (non-engineered)
Sponsor
Southwest Regional Wound Care Center

Names

NameTypeSource
WPP-201preferred name, codecurator, ctgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
bacteriophage cocktail of eight phages lytic for P. aeruginosa, S. aureus and E. coli
Replication
replicating
Route
topical
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT00663091A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg UlcersCompletedPhase 12006-092008-0564Venous Leg Ulcers

Recent changes

No changes recorded in its trials yet.

Notes

Phage preparation tested topically in venous leg ulcers in a randomised double-blind phase 1 trial, NCT00663091. Originator not taken from a primary source, so left empty. The registration describes WPP-201 as a pH-neutral polyvalent preparation of eight phages lytic for P. aeruginosa, S. aureus and E. coli.

How to cite

WPP-201 (AXP000233.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000233.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.